Unique molecular and functional features of extramedullary hematopoietic stem and progenitor cell reservoirs in humans.
Journal
Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509
Informations de publication
Date de publication:
09 06 2022
09 06 2022
Historique:
received:
23
07
2021
accepted:
05
01
2022
pubmed:
25
1
2022
medline:
14
6
2022
entrez:
24
1
2022
Statut:
ppublish
Résumé
Rare hematopoietic stem and progenitor cell (HSPC) pools outside the bone marrow (BM) contribute to blood production in stress and disease but remain ill-defined. Although nonmobilized peripheral blood (PB) is routinely sampled for clinical management, the diagnosis and monitoring potential of PB HSPCs remain untapped, as no healthy PB HSPC baseline has been reported. Here we comprehensively delineate human extramedullary HSPC compartments comparing spleen, PB, and mobilized PB to BM using single-cell RNA-sequencing and/or functional assays. We uncovered HSPC features shared by extramedullary tissues and others unique to PB. First, in contrast to actively dividing BM HSPCs, we found no evidence of substantial ongoing hematopoiesis in extramedullary tissues at steady state but report increased splenic HSPC proliferative output during stress erythropoiesis. Second, extramedullary hematopoietic stem cells/multipotent progenitors (HSCs/MPPs) from spleen, PB, and mobilized PB share a common transcriptional signature and increased abundance of lineage-primed subsets compared with BM. Third, healthy PB HSPCs display a unique bias toward erythroid-megakaryocytic differentiation. At the HSC/MPP level, this is functionally imparted by a subset of phenotypic CD71+ HSCs/MPPs, exclusively producing erythrocytes and megakaryocytes, highly abundant in PB but rare in other adult tissues. Finally, the unique erythroid-megakaryocytic-skewing of PB is perturbed with age in essential thrombocythemia and β-thalassemia. Collectively, we identify extramedullary lineage-primed HSPC reservoirs that are nonproliferative in situ and report involvement of splenic HSPCs during demand-adapted hematopoiesis. Our data also establish aberrant composition and function of circulating HSPCs as potential clinical indicators of BM dysfunction.
Identifiants
pubmed: 35073399
pii: S0006-4971(22)00110-0
doi: 10.1182/blood.2021013450
pmc: PMC7612845
mid: EMS145429
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3387-3401Subventions
Organisme : Medical Research Council
ID : MC_PC_17230
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/18/53/33863
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/W014556/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206328
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206328/Z/17/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M008975/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S036113/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107931
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107630
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2022 by The American Society of Hematology.
Références
Immunity. 2012 Dec 14;37(6):1116-29
pubmed: 23200826
Science. 2011 Jul 8;333(6039):218-21
pubmed: 21737740
J Clin Invest. 2010 Dec;120(12):4507-19
pubmed: 21060151
Transplantation. 2016 Dec;100(12):2621-2629
pubmed: 27861290
Elife. 2019 Sep 16;8:
pubmed: 31524596
Science. 2001 Nov 30;294(5548):1933-6
pubmed: 11729320
J Clin Immunol. 2020 May;40(4):554-566
pubmed: 32303876
Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9638-43
pubmed: 26195758
Mol Syst Biol. 2018 Mar 15;14(3):e8041
pubmed: 29545397
Nature. 2019 Oct;574(7778):365-371
pubmed: 31597962
Blood Adv. 2020 Dec 22;4(24):6310-6314
pubmed: 33351125
Bioinformatics. 2012 Mar 15;28(6):882-3
pubmed: 22257669
J Immunol Methods. 2009 Aug 15;347(1-2):70-8
pubmed: 19567251
Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4221-6
pubmed: 24591638
Exp Hematol. 2004 May;32(5):483-93
pubmed: 15145217
Nature. 2014 Jan 23;505(7484):555-8
pubmed: 24451543
Exp Hematol. 2004 Sep;32(9):868-76
pubmed: 15345289
Nat Immunol. 2013 Jul;14(7):756-63
pubmed: 23708252
Cell Rep. 2018 Nov 20;25(8):2083-2093.e4
pubmed: 30463007
Nat Commun. 2019 Jun 3;10(1):2395
pubmed: 31160568
Exp Hematol. 2021 Dec;104:9-16
pubmed: 34687807
Indian J Hematol Blood Transfus. 2020 Apr;36(2):309-315
pubmed: 32425382
Nat Commun. 2016 Mar 24;7:11075
pubmed: 27009448
PLoS One. 2014 Sep 02;9(9):e106717
pubmed: 25181353
Bone Marrow Transplant. 1998 Jan;21(1):79-84
pubmed: 9486499
Br J Haematol. 1999 Mar;104(3):494-8
pubmed: 10086785
Curr Stem Cell Rep. 2018 Dec;4(4):273-281
pubmed: 31131207
Nature. 2017 Apr 6;544(7648):105-109
pubmed: 28329764
Br Heart J. 1986 Jul;56(1):89-93
pubmed: 3524635
Cell Stem Cell. 2018 Oct 4;23(4):572-585.e7
pubmed: 30174297
Hepatol Res. 2014 Dec;44(14):E376-E385
pubmed: 24612092
J Biol Chem. 2010 Oct 8;285(41):31661-71
pubmed: 20682776
Cell Transplant. 2018 Oct;27(10):1417-1424
pubmed: 30235942
Nat Cell Biol. 2017 Apr;19(4):271-281
pubmed: 28319093
Blood. 2003 Aug 15;102(4):1249-53
pubmed: 12714498
Cell. 2007 Nov 30;131(5):994-1008
pubmed: 18045540
Blood. 2001 Dec 1;98(12):3249-55
pubmed: 11719361
Ultrasound Med Biol. 2006 Dec;32(12):1827-31
pubmed: 17169694
Transfusion. 2016 Apr;56(4):827-30
pubmed: 26801519
Genome Biol. 2016 May 03;17:83
pubmed: 27142433
Blood. 2015 Sep 24;126(13):1631-3
pubmed: 26405217
Exp Hematol. 2018 Dec;68:51-61
pubmed: 30243574
J Clin Invest. 2017 Sep 1;127(9):3392-3401
pubmed: 28783041
Nature. 2015 Nov 26;527(7579):466-471
pubmed: 26570997
J Immunol. 2018 Feb 1;200(3):1078-1087
pubmed: 29282309
J Exp Med. 2019 Dec 2;216(12):2778-2799
pubmed: 31601675
Nat Commun. 2018 Oct 5;9(1):4100
pubmed: 30291229
Cell Stem Cell. 2015 Mar 5;16(3):302-13
pubmed: 25704240
Pathology. 2013 Jun;45(4):408-16
pubmed: 23619587
Proc Natl Acad Sci U S A. 2001 May 8;98(10):5614-8
pubmed: 11320224
Tohoku J Exp Med. 2002 Jul;197(3):145-50
pubmed: 12365555
Blood. 2005 Apr 1;105(7):2741-8
pubmed: 15591122
Blood Adv. 2017 Feb 14;1(6):407-416
pubmed: 29296956
Exp Hematol. 2006 Nov;34(11):1573-82
pubmed: 17046577
J Exp Med. 2009 Nov 23;206(12):2837-50
pubmed: 19887396
Sci Rep. 2019 Mar 26;9(1):5233
pubmed: 30914743
Mod Pathol. 2005 Dec;18(12):1550-61
pubmed: 16118626
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Cell Stem Cell. 2012 May 4;10(5):520-30
pubmed: 22560076
Nature. 2019 Sep;573(7774):426-429
pubmed: 31485073
J Am Acad Dermatol. 1990 Feb;22(2 Pt 2):334-7
pubmed: 2303588
Sci Transl Med. 2018 Sep 12;10(458):
pubmed: 30209246
Nat Rev Immunol. 2013 May;13(5):376-89
pubmed: 23584423
Blood. 2007 Dec 1;110(12):3853-61
pubmed: 17702896
Mol Cell. 2020 May 7;78(3):477-492.e8
pubmed: 32386542
Cell Stem Cell. 2008 Oct 9;3(4):364-6
pubmed: 18940728
Cell Stem Cell. 2021 Mar 4;28(3):514-523.e9
pubmed: 33621486
Haematologica. 2013 Apr;98(4):555-9
pubmed: 23242593
Exp Hematol. 2015 Feb;43(2):100-9.e1
pubmed: 25461253
Blood. 2007 May 15;109(10):4494-502
pubmed: 17284534
Cell Stem Cell. 2021 Mar 4;28(3):502-513.e6
pubmed: 33621485
Exp Hematol. 2011 Mar;39(3):351-359.e3
pubmed: 21185906
Nat Biotechnol. 2015 May;33(5):495-502
pubmed: 25867923